{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-22-000012","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2022-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.154182+00:00","generated_at":"2026-06-27T05:10:22.072045+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ICU Medical Q4 2021 revenue up 6% to $340.5M; GAAP EPS drops to $0.91 from $1.21","bullets":["Revenue $340.5M vs $320.5M YoY; GAAP net income $19.9M ($0.91 diluted EPS) vs $26.1M ($1.21).","Adjusted diluted EPS $1.82 vs $1.77; adjusted EBITDA $64.2M vs $59.8M.","GAAP gross margin unchanged at 37%; FY2022 guidance provided in the release."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-22-000012","json":"https://secwatch.observer/filing/0000883984-22-000012.json","markdown":"https://secwatch.observer/filing/0000883984-22-000012.md","text":"https://secwatch.observer/filing/0000883984-22-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000012/0000883984-22-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000012/icui-20220224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T05:10:22.072045+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}